Eyal Ozeri

457 total citations
13 papers, 382 citations indexed

About

Eyal Ozeri is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Eyal Ozeri has authored 13 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Eyal Ozeri's work include Pancreatic function and diabetes (6 papers), Diabetes and associated disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Eyal Ozeri is often cited by papers focused on Pancreatic function and diabetes (6 papers), Diabetes and associated disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Eyal Ozeri collaborates with scholars based in Israel, Italy and United Kingdom. Eyal Ozeri's co-authors include Eli C. Lewis, Galit Shahaf, Mark Mizrahi, Ran Zichel, Israel Sekler, Arthur A. Vandenbark, Lisa Miller, Guy A. Rutter, Michal Hershfinkel and Daniel Khananshvili and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Eyal Ozeri

13 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Ozeri Israel 10 134 90 89 68 51 13 382
E.U. Sumer Denmark 10 169 1.3× 138 1.5× 58 0.7× 54 0.8× 38 0.7× 12 497
P. Bianco Italy 9 290 2.2× 64 0.7× 43 0.5× 41 0.6× 29 0.6× 14 593
Patrick Maschmeyer Germany 14 130 1.0× 44 0.5× 57 0.6× 195 2.9× 56 1.1× 21 469
Lilian Schimmel Australia 9 243 1.8× 42 0.5× 39 0.4× 115 1.7× 15 0.3× 13 539
Dragana Vujić Serbia 11 271 2.0× 61 0.7× 24 0.3× 47 0.7× 45 0.9× 43 450
Takashi Kon Japan 12 214 1.6× 82 0.9× 83 0.9× 26 0.4× 59 1.2× 37 443
Klas Strååt Sweden 14 208 1.6× 66 0.7× 45 0.5× 99 1.5× 32 0.6× 21 543
Riccardo Mesturini Italy 15 120 0.9× 25 0.3× 35 0.4× 184 2.7× 47 0.9× 18 481
Bart Krist Poland 9 217 1.6× 119 1.3× 45 0.5× 123 1.8× 21 0.4× 11 434
Ashley Weiss Canada 6 183 1.4× 188 2.1× 57 0.6× 109 1.6× 31 0.6× 7 525

Countries citing papers authored by Eyal Ozeri

Since Specialization
Citations

This map shows the geographic impact of Eyal Ozeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Ozeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Ozeri more than expected).

Fields of papers citing papers by Eyal Ozeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Ozeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Ozeri. The network helps show where Eyal Ozeri may publish in the future.

Co-authorship network of co-authors of Eyal Ozeri

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Ozeri. A scholar is included among the top collaborators of Eyal Ozeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Ozeri. Eyal Ozeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ozeri, Eyal, Peleg Rider, Galit Shahaf, et al.. (2020). Differential signaling patterns of stimulated bone marrow-derived dendritic cells under α1-antitrypsin-enriched conditions. Cellular Immunology. 361. 104281–104281. 4 indexed citations
2.
Ozeri, Eyal, et al.. (2017). Role of Homologous Fc Fragment in the Potency and Efficacy of Anti‐Botulinum Antibody Preparations. Toxins. 9(6). 180–180. 8 indexed citations
3.
Ozeri, Eyal, Galit Shahaf, David E. Ochayon, et al.. (2016). Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration. Journal of Pharmacology and Experimental Therapeutics. 359(3). 482–490. 11 indexed citations
4.
Rosen, Osnat, et al.. (2016). Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins. Toxins. 8(10). 276–276. 15 indexed citations
5.
Rosen, Osnat, Liron Feldberg, Sigalit Gura, et al.. (2015). Early, Real-Time Medical Diagnosis of Botulism by Endopeptidase-Mass Spectrometry. Clinical Infectious Diseases. 61(12). e58–e61. 9 indexed citations
7.
Schuster, Ronen, Galit Shahaf, Eyal Ozeri, et al.. (2014). α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation. Cellular and Molecular Immunology. 11(4). 377–386. 42 indexed citations
8.
Hershfinkel, Michal, Daniel Fishman, Eyal Ozeri, et al.. (2012). The Mitochondrial Na+/Ca2+ Exchanger Upregulates Glucose Dependent Ca2+ Signalling Linked to Insulin Secretion. PLoS ONE. 7(10). e46649–e46649. 63 indexed citations
9.
Ozeri, Eyal, Mark Mizrahi, Galit Shahaf, & Eli C. Lewis. (2012). α-1 Antitrypsin Promotes Semimature, IL-10–Producing and Readily Migrating Tolerogenic Dendritic Cells. The Journal of Immunology. 189(1). 146–153. 64 indexed citations
10.
Ozeri, Eyal, et al.. (2012). Revascularization of Pancreatic Islet Allografts is Enhanced by α-1-Antitrypsin under Anti-Inflammatory Conditions. Cell Transplantation. 22(11). 2119–2133. 30 indexed citations
11.
12.
Shahaf, Galit, et al.. (2011). α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection. Molecular Medicine. 17(9-10). 1000–1011. 57 indexed citations
13.
Ochayon, David E., et al.. (2010). CS1-6 Protection of insulin producing beta cells by the anti-inflammatory acute phase protein alpha-1- antitrypsin. Cytokine. 52(1-2). 6–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026